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Objectives: HIV-infected patients are at increased risk of developing mental health symptoms, which negatively
influence the treatment of the HIV-infection. Mental health problems in HIV-infected patients may affect public
health. Psychopathology, including depression and substance abuse, can increase hazardous sexual behaviour and,
with it, the chance of spreading HIV. Therefore, it is important to develop an optimal treatment plan for
HIV-infected patients with mental health problems. The majority of HIV-infected patients in the Netherlands
(almost 60%) are homosexual men.
The main objectives of this study were to describe the clinical and demographic characteristics of patients with HIV
who seek treatment for their mental health symptoms in the Netherlands. Secondly, we tested whether HIV
infected and non-infected homosexual patients with a lifetime depressive disorder differed on several mental
health symptoms.
Methods: We compared a cohort of 196 patients who visited the outpatient clinic for HIV and Mental Health with
HIV-infected patients in the general population in Amsterdam (ATHENA-study) and with non-HIV infected mental
health patients (NESDA-study). DSM-IV diagnoses were determined, and several self-report questionnaires were
used to assess mental health symptoms.
Results: Depressive disorders were the most commonly occurring diagnoses in the cohort and frequent drug use
was common. HIV-infected homosexual men with a depressive disorder showed no difference in depressive
symptoms or sleep disturbance, compared with non-infected depressive men. However, HIV-positive patients did
express more symptoms like fear, anger and guilt. Although they showed significantly more suicidal ideation,
suicide attempts were not more prevalent among HIV-infected patients. Finally, the HIV-infected depressive patients
displayed a considerably higher level of drug use than the HIV-negative group.
Conclusion: Habitual drug use is a risk factor for spreading HIV. It is also more often diagnosed in HIV-infected
homosexual men with a lifetime depression or dysthymic disorder than in the non-infected population. Untreated
mental health problems, such as depressive symptoms and use of drugs can have serious repercussions. Therefore,
general practitioners and internists should be trained to recognize mental health problems in HIV-infected patients.
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HIV is a highly stigmatized, chronic disease with a sub-
stantial co-occurrence of mental health problems [1]. On
the one hand, patients with mental health problems are at
increased risk of contracting HIV. On the other hand,
HIV-infected patients are at increased risk of developing
mental health problems compared with the general popu-
lation [2]. Mental health problems in HIV-infected patients
have a negative influence on the treatment, adherence to
treatment, and prognosis of the HIV-infection [3,4]. Simi-
lar effects have been determined for other chronic diseases,
such as diabetes and chronic obstructive pulmonary dis-
ease (COPD) [5,6]. However, there are some important dif-
ferences between HIV and other chronic diseases. First,
HIV-infected patients suffer more from shame, stigma, and
discrimination, which can also cause mental health pro-
blems [7,8]. Second, mental health problems in HIV-
infected patients can affect public health. Psychopathology
like depression and substance abuse can increase hazar-
dous sexual behaviour and, with it, the chance of spreading
HIV [9,10].
The most common mental disorders among HIV-
infected patients are depression and depressive symp-
toms. The chance of developing a depressive disorder is
two times higher in HIV-infected patients than in HIV-
negative comparison subjects [11]. Depressive symptoms
are even more common: 54% of HIV-infected patients
reported depressive symptoms in the past week [12]. Al-
though it has a high prevalence, only fewer than 50% of
the cases are recognized clinically [13]. Apart from the
HIV-infection, stigma and discrimination are associated
with an increase in depressive symptoms among HIV-
infected patients [14]. In addition, the risk of suicide and
suicide attempts is higher among HIV-infected patients
compared with the general population and compared
with patients with other chronic diseases [15].
Conversely, several mental health problems have been
identified as risk factors for contracting HIV [16,17]. For
example, depressive symptoms and the use of alcohol or
drugs, such as amphetamine, cannabis and cocaine, are
associated with increased sexually risky behaviour and an
increased risk of contracting HIV, particularly among men
who have sex with men(MSM) [18-20]. Certain personal-
ity traits of the Five-Factor Module of Personality [21] are
also associated with an increased risk. High scores on
neuroticism (chronic emotional distress, e.g. anxiety, de-
pression, impulsiveness) and low scores on agreeableness
(altruism, modesty, trust) and conscientiousness are asso-
ciated with HIV risk behaviours [22].
Mental health problems can arise and increase during
different stages of HIV, such as for example, immediately
after testing HIV-positive or after many years of living with
HIV [23]. Despite the fact that mental health problems are
poorly recognized by clinicians [13], some of the HIV-infected patients with mental health problems will seek
help at an institution for mental health. To develop an op-
timal treatment plan for this group of patients, it is im-
portant to determine the demographic characteristics,
psychiatric diagnoses and severity of the psychopathology.
In the Netherlands there is a database available that
includes demographic data of almost all HIV-positive
patients (ATHENA) [24]. We are interested in knowing
whether the mental health treatment seeking HIV-
infected population in Amsterdam differs from the general
HIV-infected population in Amsterdam on demographic
and medical characteristics.
The majority of HIV-infected patients in the Netherlands
are homosexual men. In 2010, 7532 men (58%) of the
infected HIV population (13.035) were men who have sex
with men (MSM) [24]. It is interesting, therefore, to com-
pare them with homosexual HIV-negative men.
It is unknown whether the presence of HIV has an ef-
fect on the severity of psychiatric symptoms of patients
with mental health problems. We hypothesize that HIV
may cause more severe symptoms and is associated with
more co-morbid substance use among patients with a
depressive or dysthymic disorder. Furthermore, HIV-
infected patients with mental health problems probably
show a different pattern in personality traits like neuroti-
cism, agreeableness and conscientiousness, compared
with non-infected patients with the same mental health
problems.
If treatable mental health problems, such as depressive
symptoms, alcohol and drug abuse and, to a lesser ex-
tent, personality traits are recognised and assessed, the
prognosis of the HIV-infection might be improved and
the risk of spreading HIV diminished. The present study
had two main objectives. First, we described the clinical
and demographic characteristics of patients with HIV
who seek treatment for their mental health problems in
a specialized outpatient clinic for HIV and mental health.
We subsequently compared these patients with the general
population of HIV-positive patients in the Netherlands.
Second, we tested whether HIV-infected homosexual
patients and non-infected homosexual patients with a life-
time depressive or dysthymic disorder differed on 1) de-
pressive symptoms, 2) co-morbid use of alcohol and
drugs, and 3) personality traits.
The chance of developing psychopathology is higher in
HIV-infected patients than in HIV-negative comparison
subjects [2]. However, we also expect that these symp-
toms are more severe, due to the influence of a lifelong
disease, exacerbated by stigma and discrimination.
Method
HIV-infected patients with mental health problems
We conducted the study at the outpatient clinic for HIV
and Mental Health at GGZ inGeest in Amsterdam, the
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This clinic was founded in 1984 and specializes in the
assessment and treatment of mental health problems in
HIV-infected patients. Patients can be referred to the
clinic by their infectious disease specialist, HIV-nurse,
family doctor, or regular psychologist or psychiatrist.
New patients visiting the outpatient clinic were asked
to participate in this study during their first appoint-
ment. The design and the purpose of the study were
explained and the patients gave written informed con-
sent. The Medical Ethics Review Committee of the VU
University Medical Center approved the research proto-
col and gave permission for publication.
At the intake, trained staff members obtained a DSM-IV
diagnosis by assessment, using the M.I.N.I. International
Neuropsychiatric Interview (M.I.N.I. Plus) [25]. Demo-
graphic data were recorded and all participants were asked
to fill in the assessment lists. The assistant-coordinator of
the research program contacted the patients if the assess-
ments lists were not returned. All eligible patients with
HIV and mental health problems who gave informed con-
sent and completed the questionnaires were included in
the cohort (N = 196).
Control subjects: the general HIV-population of
Amsterdam
To compare demographic and clinical characteristics of
the cohort of patients from the outpatient clinic for
HIV and Mental Health in Amsterdam with the general
HIV-positive population of Amsterdam, we selected HIV
infected patients from the ATHENA national observa-
tional HIV cohort in the Netherlands. ATHENA collects
anonymous data obtained during routine clinical care
from all HIV-infected patients in the Netherlands who re-
ceive care at one of the 25 designated HIV treatment cen-
tres [26]. In 2007, the total HIV-infected population
collected by ATHENA consisted of 12,570 patients. For
the comparison with patients from the outpatient clinic
for HIV and Mental Health, we used 5304 HIV-infected
patients from Amsterdam.
Control subjects: homosexual men with a lifetime
dysthymic or depressive disorder
For the comparison between HIV infected homosexual
patients and non-infected homosexual patients, we
selected homosexual men with a lifetime dysthymic or
depressive disorder from both the original HIV research
cohort (N = 84) and the Netherlands Study of Depres-
sion and Anxiety (NESDA) (N = 60). NESDA is a longi-
tudinal cohort study that investigates the long-term
course of depressive and anxiety disorders. A description
of the rationales, methods, and recruitment strategy is
reported elsewhere [27]. In this study, DSM-IV diagno-
ses were obtained using the World Health OrganizationComposite International Diagnostic Interview (CIDI V
2.1). Although a different diagnostic instrument was
used in NESDA than at the intake at the clinic for HIV
and mental health, both the CIDI and the MINI assess
psychiatric diagnoses according to the DSM-IV classifi-
cation. Previous studies have shown that diagnoses
obtained with the MINI and CIDI were comparable. In
the comparison between the MINI and the CIDI the
Kappa values were greater than 0.5, except for simple
phobia and GAD. Sensitivity was 0.7 or greater for all
but four values (panic, agoraphobia, simple phobia, and
lifetime bulimia). Specificity was 0.7 or greater for all
diagnoses [28].
Demographics were assessed and patients completed
several questionnaires. All respondents signed an informed
consent at baseline assessment. A total of 2981 respon-
dents, aged 18–65, were recruited from the general popu-
lation (19%), primary care (54%) and mental health care
organizations (27%) to represent various settings and
stages of psychopathology. Selection of homosexual men
with a lifetime depressive or dysthymic disorder from the
NESDA database yielded a total group of 60 patients
without HIV.
Measures
The self-report questionnaire was used to obtain mea-
sures in three domains: severity of symptoms, personality
traits, and substance use. The specific instruments were
all part of the NESDA study and allowed us to compare
the HIV study participants with the NESDA study parti-
cipants and included the following assessment lists:
Inventory of Depressive symptoms (IDS) [29]: the 30
item Inventory of Depressive Symptomatology (IDS) is
designed to assess the severity of depressive symptoms.
Beck Anxiety Index (BAI) [30]: the Beck Anxiety Inven-
tory (BAI) is a 21-item self-report instrument that assesses
the overall severity of anxiety. The BAI was developed to
address the need for an instrument that would reliably dis-
criminate anxiety from depression while displaying con-
vergent validity.
Alcohol Use Disorders Identification Test (AUDIT) [31]:
the AUDIT identifies persons with hazardous and harmful
patterns of alcohol consumption.
NEO Five-Factor Inventory (NEO-FFI) [21]: personality
traits of the Five-Factor Module of Personality, Openness
(Aesthetic Interests, Intellectual Interests, Unconven-
tionality); Agreeableness (Nonantagonistic Orientation,
Prosocial, Orientation); Conscientiousness (Orderliness,
Goal-Striving, Dependability); Extraversion (Positive Affect,
Sociability, Activity); and Neuroticism (Negative Affect,
Self- Reproach).
Fear Questionnaire [32]: the Fear Questionnaire (FQ) is
part of a standard brief self-rated form. The complete
form also includes one specific main target phobia, a
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pression symptoms.
Mood and Anxiety Symptom Questionnaire (MASQ)
[33]: the model is based on the assumption that mood can
be dissected into two components, negative affect (NA)
and positive affect (PA) and a third dimension of somatic
arousal (SA). Whereas NA is characterized by aversive
emotional states, such as fear, anger, and guilt that are
associated with both anxiety and depression, PA repre-
sents positive emotional states such as feeling active,
excited, delighted, enthusiastic, and interested. A lack of
PA is described as feeling ‘tired and sluggish’ and is asso-
ciated with depressive moods. The SA dimension repre-
sents symptoms of physiological hyper arousal, such as
trembling, shaking, dizziness, sweating, and heart racing.
Four Dimensional Symptom Questionnaire (4DSQ)
[34]: the somatization scale is one of the 4 scales of the
Four-Dimensional Symptom Questionnaire, a self-report
questionnaire designed to assess common psychological
symptoms in primary care.
Women's Health Initiative Insomnia Rating Scale
(WHI-IRS) [35]: the list consists of five questions con-
cerning sleep in the past month. The five items address
trouble falling asleep, waking up during the night, early
morning awakenings, trouble getting back to sleep after
waking up, and sleep quality. Although developed by
the WHI, the items of this instrument are not sex-
specific.
The five screening items of the Beck Scale for Suicide
Ideation (BSS) [36]: the BBS is a valuable tool for clini-
cians to examine suicidal intent in patients. Developed
for use with patients of 17 years and up, the BSS pro-
vides a good starting point for a clinician's more detailed
examination of a patient's suicidal intent.
Analyses
All statistics were performed using SPSS 15 (SPSS Inc,
Chicago, Illinois, USA). The three analyses done are 1)
Effect of the duration of HIV; 2) Comparison with
ATHENA; and 3) Comparison with depressed homosex-
ual men from NESDA. We used ANOVA to compare
group means of continuous variables and the Pearson
chi-square statistic to test for differences between groups
on discrete variables. When cells had an expected count
less than 5, the likelihood ratio is reported instead of the
Pearson chi-square statistic.
When comparing HIV-infected and non-infected de-
pressive homosexual patients, several covariates were
entered in the statistical model. A particularly important
covariate was the clinical setting. It seems likely that
patients who seek help for current mental health problems
show more symptoms of depression and anxiety than
those who do not seek help or are in remission. While all
HIV-positive patients had been referred to the mentalhealth clinic for their mental health problems, this was
only true for 42% of the HIV-negative depressed subjects.
Other covariates that we adjusted for were Dutch origin,
age, partner, and work status. Adjustments were done with
linear regression analysis for continuous outcomes, and lo-
gistic regression for dichotomous variables.
Results
Cohort of patients from the outpatient clinic for HIV and
Mental Health (N = 196)
Between March 2006 and September 2009, 291 new
patients visited the outpatient clinic for HIV and Mental
Health. 56 patients were excluded from the study because
they either had no HIV-infection, could not read and write
Dutch, or had not completed the diagnostic interview. An-
other 39 patients refused, leaving a total of 196 patients
who participated in the study. Non-responders were more
often of a non-Dutch origin (42% vs. 26%, p = 0.043) and
were less likely to have a partner (32% vs. 49%, p = 0.051).
No differences were found on other demographics or
DSM-IV diagnoses.
The demographic characteristics of the HIV-infected
patients seeking treatment are listed in Table 1. We
could not obtain all demographic characteristics from
each patient. Respondents had a mean age of 42 and the
mean age at which the HIV-infection was diagnosed was
35.The majority of the patients were homosexual men
(77.5%), 49% of the patients had a partner, and 60% had
a paid job for more than 12 hours per week. Most
patients (68%) had a history of psychiatric treatment be-
fore they came to the outpatient clinic. The majority of
the patients had Dutch nationality; however, 26% were
not originally from the Netherlands. In total, 29 different
original nationalities were represented. The level of edu-
cation was high, only 7% had only a basic education.
The respondents reported heavy drugs use 30 days prior
to the assessment: 26% had used cannabis and 27% ec-
stasy, speed or cocaine and 15% had used more than one
type of drug.
Most patients (85%) had been infected with HIV for
over one year. The average CD4-count was 488; 7% of the
patients had fewer than 200 CD4-cells/mm3. We have no
systematic information about opportunistic infections or
HIV-related tumors. The majority of patients (68%) were
on antiretroviral treatment.
Comparison with the general HIV-infected population in
Amsterdam
We found no difference between the two groups in age
of HIV diagnosis; neither did we consider the difference
in age of intake relevant. However, our cohort consisted
of more men, especially more homosexual men and
there were more patients of Dutch origin. More patients
were within the first years of their infection, and fewer
Table 1 Demographic characteristics of the 196 patients compared with 5304 patients in Amsterdam in follow-up at
the end of 2007 in the ATHENA cohort (database of the Stichting HIV Monitoring)
Amsterdam-Clinic Amsterdam-ATHENA
N or mean Valid% or range * N or mean Valid% or range p value
Age at intake 42 (± 8.8) (18–65) 43.8 (± 10.6) (1–81.9) p = 0.03
Age at HIV diagnosis 35 (± 8.8) (15–64) 35.5 (± 10.2) (0–81.5) p = 0.6
Male 172 87.7% 4380 79.6% p = 0.06
Homosexual men 148 77.5% 3437 64.8% p = 0.002
Has a partner 91 48.9%
Has a paid day job (>12 hr/week) 112 60.2%
Has a psychiatric history 128 68.4%
Has a Dutch origin 143 74.1% 2886 54.4% p < 0.0001
Drug used past 30 days 75 43.4%
Cannabis 45 26.3%
Ecstasy, speed, cocaine 46 26.9%





Years of HIV 7.0 (± 6.3) (0–25) 8.3 (± 6.0) (0–26.5) p < 0.001
0 – 1 30 15.8% 436 8.3% p < 0.001
1 – 5 65 34.2% 1458 27.9%
5 – 10 43 22.6% 1432 27.3%
> 10 52 27.4% 1910 36.5%
CD4 cells/mm3 488 (± 234.7) (20–1300) 522 (± 258) (0–2150) p = 0.1
0 – 200 11 7.0% 332 7.5% p = 0.004
201 – 500 93 58.9% 2014 45.7%
> 500 54 34.2% 2060 46.8%
Is on antiviral treatment 132 68.8% 4119 77.7% p = 0.004
* Due to missing values, the N varied from 158 (CD4 count) to 196 in the clinic and from 4406 (CD4 count) to 5304 in the ATHENA cohort.
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substantial difference appeared in the mean number of
CD4-cells, except for the number of patients with more
than 500 CD4 cells/mm3
We obtained a DSM-IV diagnosis from 196 patients of
the patients included in the study. The results are listed
in Table 2. More than 50% of the patients were diag-
nosed with a major depression disorder, a dysthymic dis-
order, or a combination of both disorders. Anxiety
disorders were less frequently present (21%). 10% of the
population was diagnosed with drugs dependence or
abuse, but only 5% with an alcohol dependence or abuse.
Bipolar and psychotic disorders were not often diag-
nosed: in total more than 4% of the patients had one of
these diagnoses. Adjustment disorders with depressive,
anxious, or mixed characteristics were diagnosed in less
than 10% of the population. Additional diagnoses like
phase of life problem, bereavement or identity problemwere determined in more than 30% of the population,
usually as an additional diagnosis, sometimes as the
main diagnosis.
Effect of the duration of the HIV-infection
We divided our patients into four groups, based on the
time since their HIV had been diagnosed. The effects of
the duration of the HIV-infection are listed in Table 3.
Patients who had been infected with HIV for more than
ten years were significantly older, were less likely to have
a paid job and more often had a history of psychiatric
treatment. No differences were found on gender, sexual
orientation or having a partner. As expected, the CD4-
count first rises and then falls. When it comes to psy-
chopathology, no significant differences were found be-
tween the four groups in terms of depressive or anxious
symptoms, suicidal ideation and suicide attempts, drug
use, or somatization.
Table 2 DSM-IV diagnosis
N %
Depression
MDD without dysthymic disorder 51 26.0%
Dysthymic disorder without MDD 34 17.3%
MDD and dysthymic disorder 18 9.2%
MDD or dysthymic disorder with
comorbid anxiety disorder
29 14.8%
Anxiety disorder 42 21.4%
Substance use (dependence or abuse)
Alcohol without drugs 11 5.6%
Drugs without alcohol 20 10.2%
Alcohol and drugs 4 2.0%
Bipolar disorder II, hypomanic or psychotic disorder 9 4.6%
Adjustment disorders 19 9.7%
Other problems (V-codes) 61 31.1%
Relational problems 16 8.2%
Additional problems (such as
bereavement, phase of life problem,
identity problem, occupational problem)
41 20.9%
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The results of the comparison between HIV-positive
and HIV-negative homosexual men with a depression or
a dysthymic disorder are listed in Table 4. There were
no differences between the two groups regarding age,
nationality, having a partner, having a paid job or educa-
tional level.
The patients with HIV were not more depressed or anx-
ious, measured using the IDS, BAI, MASQ positive affect,Table 3 Effects of the duration of the HIV-infection
0 – 1 yr 1 – 5 yr
(n = 30) (n = 65)
Age 41.0 (± 10.9) 38.9 (± 8.4)
Male 93.3% 86.2%
Homosexual men 83.3% 83.1%
Dutch origin 66.7% 70.8%
Has a partner 48.1% 44.4%
Paid job (>12 hr/week) 76.9% 69.2%
Psychiatric history 59.3% 63.1%
CD4 cells/mm3 358 (± 139.8) 470 (± 185.0)
IDS (depressive symptoms) 28.5 (± 13.28) 29.1 (± 12.33)
BAI (anxiety symptoms) 19.1 (± 12.66) 16.5 (± 10.62)
4DSQ (somatization) 44.8% 48.4%
Drug used past 30 days 32.0% 51.7%
Suicide ideation 37.9% 51.6%
Suicide attempt (life-time) 17.9% 29.5%
1 ANOVA.
2 Pearson chi-square.
3 Chi-square, likelihood ratio.
Due to missing values, the N may vary per item.and Fear Questionnaire. The MASQ negative affect showed
more symptoms like fear, anger, and guilt in the HIV-
infected patients. The HIV-infected patients showed more
suicide ideation, but did not report having committed more
suicide attempts. There was no significant difference in al-
cohol use measured using the total AUDIT-score and in
glasses per month. However, the HIV-infected patients
drank significantly more standard glasses of alcohol per
session. There was a significant difference in the amount of
drugs used 30 days prior to assessment. In fact, the HIV-
infected patients used more drugs in general: there was a
trend for higher scores on use of ecstasy, speed, cannabis,
and cocaine.
There was no difference in somatization between the two
groups, when measured using the 4DSQ and MASQ and
in sleep disturbance measured using the IRS. The results of
the NEO showed a mixed pattern: there was a trend for
higher scores on the Neuroticism-scale in the HIV-infected
population. There were no differences at the Extraversion
and Agreeableness scale, but the scores on the Openness
scale and conscientiousness scale were significantly lower.
Discussion
The patients of the cohort from the outpatient clinic for
HIV and Mental Health differ from the general HIV-
infected population in Amsterdam (ATHENA) in several
respects. In our cohort, more homosexual men with the
Dutch nationality were represented, and women and het-
erosexual men and patients with a foreign nationality were
underrepresented. It is unlikely that these patients had
fewer mental health problems [37]. Although homosexual5 – 10 yr > 10 yr p-values p-values
(n = 43) (n = 52) (overall) (0 vs.10 yrs)
41.6 (± 7.8) 47.1 (± 6.5) 0.000 1 0.002 1
86.0% 86.5% 0.723 3 0.327 3
81.4% 76.0% 0.778 2 0.438 2
74.4% 84.6% 0.234 2 0.059 2
44.2% 60.0% 0.341 2 0.318 2
58.1% 40.8% 0.005 2 0.003 2
64.3% 84.0% 0.049 2 0.016 2
601 (± 254.6) 493 (± 279.3) 0.001 1 0.026 1
33.2 (± 15.08) 28.9 (± 12.50) 0.341 1 0.910 1
20.1 (± 12.45) 14.9 (± 10.98) 0.119 1 0.117 1
47.6% 44.2% 0.969 2 0.959 2
12.5% 38.7% 0.276 2 0.581 2
50.0% 48.0% 0.762 2 0.385 2
21.6% 34.0% 0.377 2 0.131 2
Table 4 HIV-infected homosexual patients and non HIV-infected homosexual patients with a depressive
or dysthymic disorder
HIV-infected Non HIV-infected p-values p-values
(N = 84) (N = 60) (not adjusted) (adjusted *)
Age 42.2 (± 8.4) 44.3 (± 11.6) 0.204 1 0.706
Dutch origin 76.2% 93.3% 0.005 2 0.214
Has a partner 60.5% 51.7% 0.191 2 0.965
Paid job (>12 hr/week) 57.1% 61.7% 0.524 2 0.843
High educational level 54.5% 51.7% 0.738 2 0.240
(adjusted**)
IDS (depressive symptoms) 33.6 (± 12.79) 25.9 (± 13.38) 0.000 1 0.357 3
BAI (anxiety symptoms) 19.3 (± 12.26) 13.4 (± 10.65) 0.002 1 0.440 3
Fear Q 28.6 (± 19.94) 27.5 (±19.37) 0.761 1 0.210 3
Suicide ideation 53.6% 20.0% 0.000 2 0.009 4
Suicide attempt (life-time) 28.6% 30.0% 0.852 2 0.967 4
IRS (sleep) 10.6 (± 5.52) 9.45 (± 5.04) 0.224 1 0.386 3
MASQ: positive affect 39.6 (± 7.93) 37.6 (± 8.09) 0.161 1 0.248 3
MASQ: negative affect 28.8 (± 8.71) 23.0 (± 7.61) 0.000 1 0.065 3
MASQ: somatic arousal 18.9 (± 7.20) 16.6 (± 6.26) 0.065 1 0.627 3
4DSQ score 15.2 (± 10.76) 12.9 (± 10.00) 0.194 1 0.882 3
4DSQ: somatization 56.6% 50.0% 0.433 2 0.831 4
AUDIT score (alcohol use) 6.36 (± 5.69) 6.33 (± 5.59) 0.977 1 0.190 3
If drinker: glasses per month 29.9 (± 36.62) 22.9 (± 31.33) 0.279 1 0.241 3
If drinker: glasses per session 2.90 (± 1.77) 1.76 (± 1.91) 0.001 1 0.003 3
Drugs used past 30 days 54.3% 21.7% 0.000 2 0.006 4
Cannabis 33.3% 15.0% 0.016 2 0.107 4
Ecstasy, speed, cocaine 30.4% 10.0% 0.004 2 0.059 4
Heroin, LSD 1.4% 1.7% 0.921 2 0.998 4
NEO: neuroticism 42.8 (± 6.84) 39.0 (± 7.81) 0.002 1 0.055 3
NEO: extraversion 33.0 (± 7.16) 33.7 (± 7.18) 0.592 1 0.866 3
NEO: openness 32.7 (± 5.28) 39.6 (± 5.68) 0.000 1 0.000 3
NEO: agreeableness 40.5 (± 5.86) 42.0 (± 6.23) 0.162 1 0.587 3
NEO: conscientiousness 34.5 (± 6.77) 40.1 (± 6.94) 0.000 1 0.001 3
* adjusted for clinical setting.
** adjusted for clinical setting, origin, age, partner and work status.
1 ANOVA.
2 Pearson chi-square.
3 Linear regression, ANOVA.
4 Logistic regression, Pearson chi-square.
Due to missing values, the N may vary per item.
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we assume that immigrants may not arrive at the clinic as
frequently due to the stigma on mental health problems. It
is also possible that mental problems in that group of
HIV-infected patients are not sufficiently recognized by
general practitioners and internists.
At the outpatient clinic, more patients were treated
early in their HIV-infection compared to the general
population and therefore they used less antiretroviral
medication. Although we have no official data on this
subject, it is possible that part of the lower use ofmedication is caused by poor adherence, influenced by
mental health problems [3,4]. Untreated mental health
problems in HIV-infected patients can have major conse-
quences and general practitioners and internists should be
trained in recognizing mental health problems in HIV-
infected patients.
As expected, depression and dysthymic disorder were
the most commonly occurring diagnoses in the cohort.
Mood disorders are common mental disorders and the
most important reason for psychiatric referral among
HIV-infected patients [39]. Depression and HIV have a
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is an increased risk of getting HIV, and with HIV there
is an increased risk of depressive symptoms.
There are few studies on mental disorders in patients
with prolonged HIV infection and the results are incon-
sistent [40]. The present study found that those patients
who had been infected with HIV for more than 10 years
did not have more depressive or anxious symptoms, des-
pite the fact that 84% of these patients have a psychiatric
history; neither did they report more physical symptoms.
Based on our research findings, we cannot conclude that
a long-term HIV infection is associated with more de-
pressive and anxious symptoms. Patients who had been
infected with HIV for more than 10 years did not show
more anxious and depressive symptoms than patients
earlier in their infection.
Remarkably, compared with the non-infected group of
patients with a depression or dysthymic disorder, the
HIV-infected homosexual men with a depression or a dys-
thymic disorder showed no difference in depressive symp-
toms or sleep disturbance. Apparently, HIV infection is
not a risk factor for increased depressive symptoms among
homosexual men. However, there were differences be-
tween the two groups with regard to suicidal ideation and
symptoms such as guilt and anger. HIV is still a disease
surrounded by taboo and stigma, which can lead to feel-
ings of shame and anger. Although showing a higher pro-
pensity for suicidal ideation, the HIV-infected group did
not report more suicide attempts in the past, but there
were possibly more successful suicides.
The risk of suicide is increased in HIV-infected patients,
especially among gay men [15,41]. During the research
period (2006–2009), none of the patients of the cohort
died of suicide. In the Netherlands, between 2005–2009,
553 HIV-infected men died, and at least 38 of them(6.9%
of all deaths) died of suicide, 75% of whom were homosex-
ual men. In the general population, in a group comparable
in terms of age and sex, only 1.5% died of suicide [41]. Ap-
parently some of these patients did not or no longer
received psychiatric care, but most of these patients
received care in the HIV Treatment Centers. To prevent
these deaths by suicide, it is important that depressive
symptoms and suicide ideation are better recognized and
discussed, especially among homosexual men. There is
not much evidence on this subject in women and more re-
search is necessary on this particular topic.
Although the HIV-infected group drank significantly
more units per session than the non-infected group, this
difference is not clinically relevant. However, they also
used substantially more drugs than the HIV-negative
group (more than 50% of the HIV infected group had
used drugs in the past 30 days) which is a risk factor for
transmission of HIV [17-19]. It is not clear whether
patients used more drugs before their HIV infection, orthat drug use had mainly increased afterwards. However,
to prevent HIV transmission, reducing drug use is vitally
important.
Personality traits, measured using the NEO, showed a
mixed pattern. In the HIV infected group, neuroticism
showed higher results, while openness and conscien-
tiousness showed lower results. High scores on neuroti-
cism and low scores on conscientiousness are associated
with HIV risk behaviours [22]. The scores on neuroti-
cism and conscientiousness are risk factors for contract-
ing and spreading HIV. Treatment of certain personality
traits seems useful in reducing the risk of HIV risk beha-
viors, although further research is necessary to confirm
this hypothesis [42]. High scores on openness, extraver-
sion, and conscientiousness are associated with slower
HIV progression [43]. It is unclear how low scores for
openness and conscientiousness should be interpreted
for HIV progression.
The present study faces some inherent limitations. We
were only able to assess HIV infected patients who had
sought help. We have no information on the characteris-
tics of HIV infected patients with mental health problems
who did not visit our clinic. Another limitation was the
small sample size of the non-HIV-infected homosexual
patients with a depressive or dysthymic disorder, resulting
in low statistical power.
Conclusion
Depression and dysthymic disorder are the most com-
mon diagnoses among HIV-infected patients who seek
treatment for mental health problems. Although we
found no difference in severity of depressive symptoms
between HIV-infected and non HIV-infected homosex-
ual men with a depressive or dysthymic disorder, the
HIV-infected patients show more feelings of anger and
guilt and experience more suicide ideation. Habitual
drug use and different personality traits, such as neuroti-
cism and lack of conscientiousness, are risk factors for
contracting and spreading HIV. These risk factors are
more often diagnosed in HIV-infected homosexual men
with a lifetime depression or dysthymic disorder than
the non-infected population. Untreated mental health
problems in HIV-infected patients can have serious con-
sequences. General practitioners and internists should
be trained to recognize mental health problems in HIV-
infected patients.
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